Position in INCY
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$7,851,019
-$128,016 QoQ
Shares Held
83,415
+3.3% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Crossmark Global Holdings, Inc. holds $39,668,975 across 33 Biotechnology names. INCY ranks #1 (19.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
This page
|
83,415 | $7,851,019 | |
| 2 | ARGX |
Argenx SE
|
8,668 | $6,329,807 | |
| 3 | EXEL |
Exelixis, Inc.
|
79,230 | $3,398,174 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
51,090 | $2,886,074 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
7,661 | $2,275,087 | |
| 6 | ASND |
Ascendis Pharma A/S
|
7,783 | $1,780,205 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
6,534 | $1,235,252 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,704 | $1,207,444 |
All Filings in INCY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,851,019 | 83,415 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $7,979,035 | 80,784 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $6,260,674 | 73,820 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,244,857 | 77,017 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $3,018,417 | 49,850 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $3,451,980 | 49,978 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $1,657,721 | 25,079 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,503,557 | 24,803 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $1,593,962 | 27,979 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,046,576 | 32,594 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,938,471 | 33,555 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,568,015 | 25,189 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $3,198,741 | 44,261 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,099,885 | 26,144 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $1,827,201 | 27,419 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $1,588,607 | 20,911 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $1,541,620 | 19,411 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,366,781 | 18,621 | Shares | Sole | 2022-01-10 | |
| 2021-09-30 | $1,282,127 | 18,641 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $1,514,424 | 18,001 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $1,434,496 | 17,651 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $1,633,571 | 18,781 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $2,549,603 | 28,411 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $2,880,696 | 27,707 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $2,171,049 | 29,647 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||